Frequency and Antimicrobial Susceptibility of Klebsiella Species Isolated from Urine Cultures at a Tertiary Healthcare Facility of Lahore
DOI:
https://doi.org/10.59058/jaimc.2024.22.1.224Keywords:
Antibiotic susceptibility, Frequency, Klebsiella, UTIAbstract
Background and Objective: Klebsiella is found ubiquitously in nature and is a potential pathogen to infect
different anatomic sites including urinary tract. Due to high resistance to antimicrobials it is considered as
one of the most challenging pathogens. The study aimed to determine the frequency and antimicrobial
sensitivity of Klebsiella species isolated from urine.
Methods: The data of urine cultures conducted during 1st Sep 2021 to 31st Aug 2022 was collected through
Electronic Medical Record system. Uropathogens were recognized based on culture characteristics and
biochemical tests with API-20E (bioMérieux) profile. Antibiotic susceptibility and extended spectrum beta-
lactamase (ESBL) detection was performed by disc/combined disc diffusion using Kirby Bauer method.
Results: Of 2438 urine samples submitted for culture during the study period, 746 (30.6%) showed significant
growth of a known uropathogen. The frequency of Klebsiella was 14.75% which was second most common
uropathogen after E. coli (57.37%). Other isolates reported were Enterococcus (12.87%), Candida (8.71%),
Pseudomonas (2.68%), Staphylococcus (1.48%), Proteus (1.07%) and Citrobacter species (1.07%). The isolates
showed high sensitivity to imipenem (87.3%) followed by meropenem (85.5%), amikacin (84.6%) and
fosfomycin (81.5%). A reduced sensitivity was observed against gentamicin (68.2%), piperacillin-tazobactam
(61.8%), nitrofurantoin (58.2%) and cefotaxime (50%), but the least sensitivity was seen for ciprofloxacin
(40.9%), cotrimoxazole (36.4%), cefuroxime (20%) and ampicillin (10%). Of all isolates 37 (33.6%) were
ESBL producers.
Conclusion: Carbapenems, amikacin and possibly fosfomycin are the most efficient drugs for treating UTI
due to Klebsiella species in our hospital setting. An on-going surveillance for ESBL producers as well as
carbapenemase-producing Klebsiella pneumoniae (KPC) is needed.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Tariq Mahmud Tariq, Samia Shabbir, Mariam Danish Iqbal, Asma Akhtar, Sana Fatima Dogar (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.